The Asia Pacific biopharma excipients market size is poised to reach USD 791.4 million by 2025, exhibiting a CAGR of 6.63% during the forecast period. Patent expiry of blockbuster biologics such as Erbitux, Rituxan, Herceptin, Avastin, Aranesp, and Enbrel by 2030 is encouraging investments in biosimilars R&D by biopharma players. Soaring need for novel additives for development of biologics such as those enhancing lyophilization performance to improve stability of biologics is anticipated to boost the demand for excipients.
As per drug sales record of 2016, eight out of ten top-selling drugs are biologics. Upcoming patent expiry of biologics is leading to increased R&D for biosimilar formulations. Biopharma players in the market are adopting price reduction strategies in order to promote their products. This is triggering the need for consideration of pricing strategy among excipient manufacturers.
Presence of challenges in development of a stable form of biotherapeutic is urging manufacturers to develop novel excipients. Processing and storage of biomolecules are complicated as these products undergo degradation after a slight change in environmental conditions. Rising demand for chemicals that are compatible with these biomolecules and serve additional functions such as binding, bulking, and efficient delivery is stimulating the growth of the market. Technological advancements, such as implementation of nanotechnology in the development of novel compounds to enhance drug delivery, are likely to drive the market. For instance, an Australian provider of microencapsulation for drug delivery, Ceramisphere, expanded its operations for production of nanoparticles with extended-release capacity.
Furthermore, Asian countries such as India & China serve as major markets for biogenerics. Key pharmaceutical players in the market are increasing their R&D activities on follow-on-biologic. Biologics R&D is outsourced to CROs in the region as a consequence of cost efficiency provided by them, which is consequently boosting the demand for excipients.
Further key findings from the report suggest:
This product will be delivered within 1-3 business days.
As per drug sales record of 2016, eight out of ten top-selling drugs are biologics. Upcoming patent expiry of biologics is leading to increased R&D for biosimilar formulations. Biopharma players in the market are adopting price reduction strategies in order to promote their products. This is triggering the need for consideration of pricing strategy among excipient manufacturers.
Presence of challenges in development of a stable form of biotherapeutic is urging manufacturers to develop novel excipients. Processing and storage of biomolecules are complicated as these products undergo degradation after a slight change in environmental conditions. Rising demand for chemicals that are compatible with these biomolecules and serve additional functions such as binding, bulking, and efficient delivery is stimulating the growth of the market. Technological advancements, such as implementation of nanotechnology in the development of novel compounds to enhance drug delivery, are likely to drive the market. For instance, an Australian provider of microencapsulation for drug delivery, Ceramisphere, expanded its operations for production of nanoparticles with extended-release capacity.
Furthermore, Asian countries such as India & China serve as major markets for biogenerics. Key pharmaceutical players in the market are increasing their R&D activities on follow-on-biologic. Biologics R&D is outsourced to CROs in the region as a consequence of cost efficiency provided by them, which is consequently boosting the demand for excipients.
Further key findings from the report suggest:
- Carbohydrates accounted the largest revenue share due to substantial product penetration in the market owing to higher availability of raw materials as well as easy molecular processing characteristics
- In terms of revenue, the polyols segment is projected to expand at a CAGR of 6.90% during the forecast period
- Japan dominated the market in terms of revenue. However, in terms of sale volume, the Japanese economy was not on the top as a consequence of high product pricing
- In February 2014, International Pharmaceutical Excipients Council of India (IPEC) was launched. Leading international pharmaceutical companies are founder members of this council, which includes Dow Chemicals, Lubrizol, BASF, SPI Pharma, Colorcon, Indchem International. It is estimated to assist the government of India in evolving direction, standards, and development of the excipient industry in the country, thus working in favor of the market
- In August 2016, China FDA announced to review excipients as a part of new drug application. The former system considered separate review approvals for a drug, its excipient, and its active ingredient.
- Some key companies present in the market are Roquette, DFE Pharma, Pharmonix, Spectrum Chemical Manufacturing Corp., IMCD, Clariant, Signet Chemical Corporation Pvt. Ltd., Sigachi Industries Pvt. Ltd., ABITEC, Colorcon, Meggle AG, SPI Pharma, and BASF SE.
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1 Executive Summary1.1 Market Snapshot
Chapter 2 Research Methodology
2.1 Information procurement
2.1.1 Purchased database:
2.1.2 Internal database
2.2 Information or Data Analysis
2.3 Market Formulation & Validation
2.4 Approaches for Market Estimation
2.4.1 Approach 1: Commodity flow & bottom up approach
2.4.2 Approach 2: Top down and parent market analysis
Chapter 3 Asia Pacific Biopharma Excipients Market Variables, Trends& Scope
3.1 Market Segmentation &Scope
3.1.1 Market driver analysis
3.1.1.1 Need for novel excipients in biologics/biosimilars development
3.1.1.2 Increasing focus of pharma players on biogeneric market
3.1.1.3 Cost-efficiency and competency of manufacturers
3.1.1.4 Patent expiry of biological actives
3.1.2 Market restraint analysis
3.1.2.1 Challenges in development of excipients for biologics
3.1.2.2 Problems in supply chain
3.1.2.3 Patent challenges and disputes over biosimilars
3.2 Penetration & Growth Prospect Mapping for Products, 2017
3.3 Biopharma Excipients Market-SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis - Porter’s
Chapter 4 Asia Pacific Biopharma Excipients Market Categorization: Product Estimates & Trend Analysis
4.1 Asia Pacific Biopharma Excipients Market: Product Movement Analysis
4.2 Solubilizers & Surfactants/Emulsifiers
4.2.1 Asia Pacific solubilizers & surfactants/emulsifiers market, by revenue 2014 - 2025 (USD Million)
4.2.2 Asia Pacific solubilizers & surfactants/emulsifiers market, by volume 2014 - 2025 (Tons)
4.2.3 Triglycerides
4.2.3.1 Asia Pacific triglycerides market, by revenue 2014 - 2025 (USD Million)
4.2.3.2 Asia Pacific triglycerides market, by volume 2014 - 2025 (Tons)
4.2.4 Esters
4.2.4.1 Asia Pacific esters market, by revenue 2014 - 2025 (USD Million)
4.2.4.2 Asia Pacific esters market, by volume by 2014 - 2025 (Tons)
4.2.5 Other solubilizer
4.2.5.1 Asia Pacific other solubilizers market, by revenue 2014 - 2025 (USD Million)
4.2.5.2 Asia Pacific other solubilizers market, by volume 2014 - 2025 (Tons)
4.3 Polyols
4.3.1 Asia Pacific polyols market, by revenue 2014 - 2025 (USD Million)
4.3.2 Asia Pacific polyols market, by volume 2014 - 2025 (Tons)
4.3.3 Mannitol
4.3.3.1 Asia Pacific mannitol market, by revenue 2014 - 2025 (USD Million)
4.3.3.2 Asia Pacific mannitol market, by volume 2014 - 2025 (Tons)
4.3.4 Sorbitol
4.3.4.1 Asia Pacific sorbitol market, by revenue 2014 - 2025 (USD Million)
4.3.4.2 Asia Pacific sorbitol market, by volume 2014 - 2025 (Tons)
4.3.5 Other polyols
4.3.5.1 Asia Pacific other polyols market, by revenue 2014 - 2025 (USD Million)
4.3.5.2 Asia Pacific other polyols market, by volume 2014 - 2025 (Tons)
4.4 Carbohydrates
4.4.1 Asia Pacific carbohydrates market, by revenue 2014 - 2025 (USD Million)
4.4.2 Asia Pacific carbohydrates market, by volume 2014 - 2025 (Tons)
4.4.3 Dextrose
4.4.3.1 Asia Pacific dextrose market, by revenue 2014 - 2025 (USD Million)
4.4.3.2 Asia Pacific dextrose market, by volume 2014 - 2025 (Tons)
4.4.4 Sucrose
4.4.4.1 Asia Pacific sucrose market, by revenue 2014 - 2025 (USD Million)
4.4.4.2 Asia Pacific sucrose market, by volume 2014 - 2025 (Tons)
4.4.5 Starch
4.4.5.1 Asia Pacific starch market, by revenue 2014 - 2025 (USD Million)
4.4.5.2 Asia Pacific starch market, by volume 2014 - 2025 (Tons)
4.4.6 Others
4.4.6.1 Asia Pacific other carbohydrates market, by revenue 2014 - 2025 (USD Million)
4.4.6.2 Asia Pacific other carbohydrates market, by volume 2014 - 2025 (Tons)
4.5 Specialty Biopharma Excipients/Others
4.5.1 Asia Pacific specialty biopharma excipients/others market, by revenue 2014 - 2025 (USD Million)
4.5.2 Asia Pacific specialty biopharma excipients/others market, by volume 2014 - 2025 (Tons)
Chapter 5 Asia Pacific Biopharma Excipients Market Categorization: Regional Estimates & Trend Analysis
5.1 Asia Pacific Biopharma Excipients Market: Regional Movement Analysis
5.2 Japan
5.2.1 Japan biopharma excipients market, by revenue 2014 - 2025 (USD Million)
5.2.2 Japan biopharma excipients market, by volume 2014 - 2025 (Tons)
5.3 China
5.3.1 China biopharma excipients market, by revenue 2014 - 2025 (USD Million)
5.3.2 China biopharma excipients market, by volume 2014 - 2025 (Tons)
5.4 India
5.4.1 India biopharma excipients market, by revenue 2014 - 2025 (USD Million)
5.4.2 India biopharma excipients market, by volume 2014 - 2025 (Tons)
5.5 Malaysia
5.5.1 Malaysia biopharma excipients market, by revenue 2014 - 2025 (USD Million)
5.5.2 Malaysia biopharma excipients market, by volume 2014 - 2025 (Tons)
5.6 South Korea
5.6.1 South Korea biopharma excipients market, by revenue 2014 - 2025 (USD Million)
5.6.2 South Korea biopharma excipients market, by volume 2014 - 2025 (Tons)
5.7 Philippines
5.7.1 Philippines biopharma excipients market, by revenue 2014 - 2025 (USD Million)
5.7.2 Philippines biopharma excipients market, by volume 2014 - 2025 (Tons)
5.8 New Zealand
5.8.1 New Zealand biopharma excipients market, by revenue 2014 - 2025 (USD Million)
5.8.2 New Zealand biopharma excipients market, by volume 2014 - 2025 (Tons)
5.9 Australia
5.9.1 Australia biopharma excipients market, by revenue 2014 - 2025 (USD Million)
5.9.2 Australia biopharma excipients market, by volume 2014 - 2025 (Tons)
5.10 Singapore
5.10.1 Singapore biopharma excipients market, by revenue 2014 - 2025 (USD Million)
5.10.2 Singapore biopharma excipients market, by volume 2014 - 2025 (Tons)
5.11 Indonesia
5.11.1 Indonesia biopharma excipients market, by revenue 2014 - 2025 (USD Million)
5.11.2 Indonesia biopharma excipients market, by volume 2014 - 2025 (Tons)
Chapter 6 Competitive Landscape
6.1 Strategy Framework
6.2 Market Participation Categorization
6.3 Company Profiles
6.3.1 Merck KGaA
6.3.1.1 Company overview
6.3.1.1.1 Merck Millipore
6.3.1.2 Financial performance
6.3.1.3 Product benchmarking
6.3.1.4 Strategic initiatives
6.3.2 Signet Chemical Corporation Pvt. Ltd.
6.3.2.1 Company overview
6.3.2.2 Financial performance
6.3.2.3 Product benchmarking
6.3.2.4 Strategic initiatives
6.3.3 Sigachi Industries Pvt. Ltd.
6.3.3.1 Company Overview
6.3.3.2 Financial performance
6.3.3.3 Product benchmarking
6.3.3.4 Strategic initiatives
6.3.4 ABITEC
6.3.4.1 Company overview
6.3.4.2 Financial performance
6.3.4.3 Product benchmarking
6.3.4.4 Strategic initiatives
6.3.5 Spectrum Chemical Manufacturing Corp.
6.3.5.1 Company overview
6.3.5.2 Financial performance
6.3.5.3 Product benchmarking
6.3.5.4 Strategic initiatives
6.3.6 Roquette
6.3.6.1 Company overview
6.3.6.2 Financial performance
6.3.6.3 Product benchmarking
6.3.6.4 Strategic initiatives
6.3.7 IMCD
6.3.7.1 Company overview
6.3.7.1.1 Indchem International
6.3.7.2 Financial performance
6.3.7.2.1 Financial performance (Indchem International)
6.3.7.3 Product benchmarking
6.3.7.4 Strategic initiatives
6.3.8 Pharmonix
6.3.8.1 Company overview
6.3.8.2 Financial performance
6.3.8.3 Product benchmarking
6.3.8.4 Strategic initiatives
6.3.9 Clariant
6.3.9.1 Company overview
6.3.9.2 Financial performance
6.3.9.3 Product benchmarking
6.3.9.4 Strategic initiatives
6.3.10 DFE Pharma
6.3.10.1 Company overview
6.3.10.2 Financial performance
6.3.10.3 Product benchmarking
6.3.10.4 Strategic initiatives
6.3.11 Colorcon
6.3.11.1 Company overview
6.3.11.2 Financial performance
6.3.11.3 Product benchmarking
6.3.11.4 Strategic initiatives
6.3.12 SPI Pharma
6.3.12.1 Company overview
6.3.12.2 Financial performance
6.3.12.3 Product benchmarking
6.3.12.4 Strategic initiatives
6.3.13 JRS PHARMA
6.3.13.1 Company overview
6.3.13.2 Financial performance
6.3.13.3 Product benchmarking
6.3.13.4 Strategic initiatives
6.3.14 BASF SE
6.3.14.1 Company overview
6.3.14.2 Financial performance
6.3.14.3 Product benchmarking
6.3.14.4 Strategic initiatives
List of Tables
Table 1 List of biosimilars approved and marketed in India
Table 2 List of top 10 drugs in 2016 by sales
Table 3 Chemically reactive oxidation products formed by use of Polysorbate 80
Table 4 The frequency of inclusion of polyols in mAb formulations (%)
Table 5 Top selling biopharmaceuticals in Japan: 2015
Table 6 Japan biopharma excipients market revenue, by product, 2014 - 2025 (USD million)
Table 7 Japan solubilizers & surfactants/emulsifiers excipients market revenue, by product, 2014 - 2025 (USD million)
Table 8 Japan polyol excipients market revenue, by product, 2014 - 2025 (USD million)
Table 9 Japan carbohydrate excipients market revenue, by product, 2014 - 2025 (USD million)
Table 10 China biopharma excipients market revenue, by product, 2014 - 2025 (USD million)
Table 11 China solubilizers & surfactants/emulsifiers excipients market revenue, by product, 2014 - 2025 (USD million)
Table 12 China polyol excipients market revenue, by product, 2014 - 2025 (USD million)
Table 13 China carbohydrate excipients market revenue, by product, 2014 - 2025 (USD million)
Table 14 India biopharma excipients market revenue, by product, 2014 - 2025 (USD million)
Table 15 India solubilizers & surfactants/emulsifiers excipients market revenue, by product, 2014 - 2025 (USD million)
Table 16 India polyol excipients market revenue, by product, 2014 - 2025 (USD million)
Table 17 India carbohydrate excipients market revenue, by product, 2014 - 2025 (USD million)
Table 18 Malaysia biopharma excipients market revenue, by product, 2014 - 2025 (USD million)
Table 19 Malaysia solubilizers & surfactants/emulsifiers excipients market revenue, by product, 2014 - 2025 (USD million)
Table 20 Malaysia polyol excipients market revenue, by product, 2014 - 2025 (USD million)
Table 21 Malaysia carbohydrate excipients market revenue, by product, 2014 - 2025 (USD million)
Table 22 South Korea biopharma excipients market revenue, by product, 2014 - 2025 (USD million)
Table 23 South Korea solubilizers & surfactants/emulsifiers excipients market revenue, by product, 2014 - 2025 (USD million)
Table 24 South Korea polyol excipients market revenue, by product, 2014 - 2025 (USD million)
Table 25 South Korea carbohydrate excipients market revenue, by product, 2014 - 2025 (USD million)
Table 26 Philippines biopharma excipients market revenue, by product, 2014 - 2025 (USD million)
Table 27 Philippines solubilizers & surfactants/emulsifiers excipients market revenue, by product, 2014 - 2025 (USD million)
Table 28 Philippines polyol excipients market revenue, by product, 2014 - 2025 (USD million)
Table 29 Philippines carbohydrate excipients market revenue, by product, 2014 - 2025 (USD million)
Table 30 New Zealand biopharma excipients market revenue, by product, 2014 - 2025 (USD million)
Table 31 New Zealand solubilizers & surfactants/emulsifiers excipients market revenue, by product, 2014 - 2025 (USD million)
Table 32 New Zealand polyol excipients market revenue, by product, 2014 - 2025 (USD million)
Table 33 New Zealand carbohydrate excipients market revenue, by product, 2014 - 2025 (USD million)
Table 34 Australia biopharma excipients market revenue, by product, 2014 - 2025 (USD million)
Table 35 Australia solubilizers & surfactants/emulsifiers excipients market revenue, by product, 2014 - 2025 (USD million)
Table 36 Australia polyol excipients market revenue, by product, 2014 - 2025 (USD million)
Table 37 Australia carbohydrate excipients market revenue, by product, 2014 - 2025 (USD million)
Table 38 Singapore biopharma excipients market revenue, by product, 2014 - 2025 (USD million)
Table 39 Singapore solubilizers & surfactants/emulsifiers excipients market revenue, by product, 2014 - 2025 (USD million)
Table 40 Singapore polyol excipients market revenue, by product, 2014 - 2025 (USD million)
Table 41 Singapore carbohydrate excipients market revenue, by product, 2014 - 2025 (USD million)
Table 42 Indonesia biopharma excipients market revenue, by product, 2014 - 2025 (USD million)
Table 43 Indonesia solubilizers & surfactants/emulsifiers excipients market revenue, by product, 2014 - 2025 (USD million)
Table 44 Indonesia polyol excipients market revenue, by product, 2014 - 2025 (USD million)
Table 45 Indonesia carbohydrate excipients market revenue, by product, 2014 - 2025 (USD million)
List of Figures
FIG. 1 Market snapshot
FIG. 2 Market research process
FIG. 3 Information Procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value chain based sizing & forecasting
FIG. 7 QFD modelling for market share assessment
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Advancements in biologic formulations and some examples of novel excipients
FIG. 12 Market restraint relevance analysis (Current & future impact)
FIG. 13 Penetration & growth prospect mapping for Products, 2017
FIG. 14 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 15 Porter’s Five Forces Analysis
FIG. 16 Asia Pacific biopharma excipients market: Product outlook key takeaways
FIG. 17 Asia Pacific biopharma excipients market: Product movement analysis
FIG. 18 Asia Pacific solubilizers & surfactants/emulsifiers market, by revenue 2014 - 2025 (USD Million)
FIG. 19 Asia Pacific solubilizers & surfactants/emulsifiers market, by volume 2014 - 2025 (Tons)
FIG. 20 Asia Pacific triglycerides market, by revenue 2014 - 2025 (USD Million)
FIG. 21 Asia Pacific triglycerides market, by volume 2014 - 2025 (Tons)
FIG. 22 Asia Pacific esters market, by revenue 2014 - 2025 (USD Million)
FIG. 23 Asia Pacific esters market, by volume 2014 - 2025 (Tons)
FIG. 24 Asia Pacific other solubilizers market, by revenue 2014 - 2025 (USD Million)
FIG. 25 Asia Pacific other solubilizers market, by volume 2014 - 2025 (Tons)
FIG. 26 Asia Pacific polyols market, by revenue 2014 - 2025 (USD Million)
FIG. 27 Asia Pacific polyols market, by volume 2014 - 2025 (Tons)
FIG. 28 Asia Pacific mannitol market, by revenue 2014 - 2025 (USD Million)
FIG. 29 Asia Pacific mannitol market, by volume 2014 - 2025 (Tons)
FIG. 30 Asia Pacific sorbitol market, by revenue 2014 - 2025 (USD Million)
FIG. 31 Asia Pacific sorbitol market, 2014 - 2025 (Tons)
FIG. 32 Asia Pacific other polyols market, by revenue 2014 - 2025 (USD Million)
FIG. 33 Asia Pacific other polyols market, by volume 2014 - 2025 (Tons)
FIG. 34 Asia Pacific carbohydrates market, by revenue 2014 - 2025 (USD Million)
FIG. 35 Asia Pacific carbohydrates market, by volume 2014 - 2025 (Tons)
FIG. 36 Asia Pacific dextrose market, by revenue 2014 - 2025 (USD Million)
FIG. 37 Asia Pacific dextrose market, by volume 2014 - 2025 (Tons)
FIG. 38 Asia Pacific sucrose market, by revenue 2014 - 2025 (USD Million)
FIG. 39 Asia Pacific sucrose market, by volume 2014 - 2025 (Tons)
FIG. 40 Asia Pacific starch market, by revenue 2014 - 2025 (USD Million)
FIG. 41 Asia Pacific starch market, by volume 2014 - 2025 (Tons)
FIG. 42 Asia Pacific other carbohydrates market, by revenue 2014 - 2025 (USD Million)
FIG. 43 Asia Pacific other carbohydrates market, by volume 2014 - 2025 (Tons)
FIG. 44 Asia Pacific specialty biopharma excipients/others market, by revenue 2014 - 2025 (USD Million)
FIG. 45 Asia Pacific specialty biopharma excipients/others market, by volume 2014 - 2025 (Tons)
FIG. 46 Asia Pacific biopharma excipients market: Region movement analysis
FIG. 47 Japan: Biosimilars Approval by PMDA
FIG. 48 Japan biopharma excipients market, by revenue 2014 - 2025 (USD Million)
FIG. 49 Japan biopharma excipients market, by volume 2014 - 2025 (Tons)
FIG. 50 China biopharma excipients market, by revenue 2014 - 2025 (USD Million)
FIG. 51 China biopharma excipients market, by volume 2014 - 2025 (Tons)
FIG. 52 India biopharma excipients market, by revenue 2014 - 2025 (USD Million)
FIG. 53 India biopharma excipients market, by volume 2014 - 2025 (Tons)
FIG. 54 Malaysia biopharma excipients market, by revenue 2014 - 2025 (USD Million)
FIG. 55 Malaysia biopharma excipients market, by volume 2014 - 2025 (Tons)
FIG. 56 South Korea biopharma excipients market, by revenue 2014 - 2025 (USD Million)
FIG. 57 South Korea biopharma excipients market, by volume 2014 - 2025 (Tons)
FIG. 58 Philippines biopharma excipients market, by revenue 2014 - 2025 (USD Million)
FIG. 59 Philippines biopharma excipients market, by volume 2014 - 2025 (Tons)
FIG. 60 New Zealand biopharma excipients market, by revenue 2014 - 2025 (USD Million)
FIG. 61 New Zealand biopharma excipients market, by volume 2014 - 2025 (Tons)
FIG. 62 Australia biopharma excipients market, by revenue 2014 - 2025 (USD Million)
FIG. 63 Australia biopharma excipients market, by volume 2014 - 2025 (Tons)
FIG. 64 Singapore biopharma excipients market, by revenue 2014 - 2025 (USD Million)
FIG. 65 Singapore biopharma excipients market, by volume 2014 - 2025 (Tons)
FIG. 66 Indonesia biopharma excipients market, by revenue 2014 - 2025 (USD Million)
FIG. 67 Indonesia biopharma excipients market, by volume 2014 - 2025 (Tons)
FIG. 68 Strategy framework
FIG. 69 Participant categorization
Companies Mentioned
- Merck KGaA
- Signet Chemical Corporation Pvt. Ltd.
- Sigachi Industries Pvt. Ltd.
- ABITEC
- Spectrum Chemical Manufacturing Corp.
- Roquette
- IMCD
- Pharmonix
- Clariant
- DFE Pharma
- Colorcon
- SPI Pharma
- JRS PHARMA
- BASF SE
Methodology
LOADING...
